[
  {
    "ts": null,
    "headline": "CVS Up on Medicare Advantage Strength: Is It a Buy Before Q2 Earnings?",
    "summary": "CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.",
    "url": "https://finnhub.io/api/news?id=648643776ced106720237054d150ae246b3eba78191333ac9d24f1b7d867ade4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752519600,
      "headline": "CVS Up on Medicare Advantage Strength: Is It a Buy Before Q2 Earnings?",
      "id": 135931794,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.",
      "url": "https://finnhub.io/api/news?id=648643776ced106720237054d150ae246b3eba78191333ac9d24f1b7d867ade4"
    }
  },
  {
    "ts": null,
    "headline": "Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits?",
    "summary": "ELV's second-quarter earnings may face pressure as rising costs and lower Medicaid memberships offset strong revenue gains.",
    "url": "https://finnhub.io/api/news?id=8f9a2b6f68e4ca8199ed370e54999788f3ebb0769f434aa3cd16c28f2d015e4a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752505680,
      "headline": "Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits?",
      "id": 135932259,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "ELV's second-quarter earnings may face pressure as rising costs and lower Medicaid memberships offset strong revenue gains.",
      "url": "https://finnhub.io/api/news?id=8f9a2b6f68e4ca8199ed370e54999788f3ebb0769f434aa3cd16c28f2d015e4a"
    }
  },
  {
    "ts": null,
    "headline": "Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?",
    "summary": "Here is how Agenus (AGEN) and CVS Health (CVS) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=3e98c6dc4607ac78fa8c39dc6f3e4eeeb56cc56b782893cbd8ae4a542705753b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752500403,
      "headline": "Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?",
      "id": 135927898,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Here is how Agenus (AGEN) and CVS Health (CVS) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=3e98c6dc4607ac78fa8c39dc6f3e4eeeb56cc56b782893cbd8ae4a542705753b"
    }
  },
  {
    "ts": null,
    "headline": "ABT to Report Q2 Earnings: CGM and Cardiac Devices in Focus",
    "summary": "Abbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments.",
    "url": "https://finnhub.io/api/news?id=e3d10cbd64e59a767e6ceb1d1b5c3accf019c9d7f1ebcf7711057b7d471ddbe6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752496140,
      "headline": "ABT to Report Q2 Earnings: CGM and Cardiac Devices in Focus",
      "id": 135927614,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Abbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments.",
      "url": "https://finnhub.io/api/news?id=e3d10cbd64e59a767e6ceb1d1b5c3accf019c9d7f1ebcf7711057b7d471ddbe6"
    }
  },
  {
    "ts": null,
    "headline": "Jefferies Maintains ‘Buy’ Rating on CVS Health Corporation (CVS); Raises PT",
    "summary": "Billionaire Kerr Neilson has bought over $290,715 worth of shares in CVS Health Corporation (NYSE:CVS), representing 0.02% of his stock portfolio, securing the company a spot in Billionaire Kerr Neilson’s 10 Stock Picks with Huge Upside Potential. On June 30, 2025, Jefferies increased its price target on CVS Health Corporation (NYSE:CVS) from $74 to $80. […]",
    "url": "https://finnhub.io/api/news?id=d33ee007c84a2fbde35cefb05e3792f6c91b9160c3f650a328c22d2db3bbe19e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752495658,
      "headline": "Jefferies Maintains ‘Buy’ Rating on CVS Health Corporation (CVS); Raises PT",
      "id": 135927901,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Billionaire Kerr Neilson has bought over $290,715 worth of shares in CVS Health Corporation (NYSE:CVS), representing 0.02% of his stock portfolio, securing the company a spot in Billionaire Kerr Neilson’s 10 Stock Picks with Huge Upside Potential. On June 30, 2025, Jefferies increased its price target on CVS Health Corporation (NYSE:CVS) from $74 to $80. […]",
      "url": "https://finnhub.io/api/news?id=d33ee007c84a2fbde35cefb05e3792f6c91b9160c3f650a328c22d2db3bbe19e"
    }
  },
  {
    "ts": null,
    "headline": "Trump's spending bill will likely boost costs for insurers, shrink Medicaid coverage",
    "summary": "NEW YORK (Reuters) -President Donald Trump's spending bill is set to raise administrative costs and make managing costs more difficult for insurers like UnitedHealthcare and CVS Health's Aetna that operate Medicaid health plans, experts say.  As a result, those insurers will likely pull back their Medicaid coverage and invest more in existing markets to retain their healthier members, experts said.",
    "url": "https://finnhub.io/api/news?id=71d1ea514997d77cd40c6a02edd371b3aa3e5f74af302b5426fb77724a7609af",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752487360,
      "headline": "Trump's spending bill will likely boost costs for insurers, shrink Medicaid coverage",
      "id": 135927903,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "NEW YORK (Reuters) -President Donald Trump's spending bill is set to raise administrative costs and make managing costs more difficult for insurers like UnitedHealthcare and CVS Health's Aetna that operate Medicaid health plans, experts say.  As a result, those insurers will likely pull back their Medicaid coverage and invest more in existing markets to retain their healthier members, experts said.",
      "url": "https://finnhub.io/api/news?id=71d1ea514997d77cd40c6a02edd371b3aa3e5f74af302b5426fb77724a7609af"
    }
  }
]